CVRX INC. - COMMON STOCK
15.27
14-February-25 10:11:08
15 minutes delayed
Stocks
+0.78
+5.38%
Today's range
14.56 - 15.38
ISIN
N/A
Source
NASDAQ
-
16 Apr 2024 15:30:00 By Nasdaq GlobeNewswire
-
CVRx announces availability of additional data supporting long-term benefits of Barostim
15 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
CVRx Announces Appointment of Kevin Hykes as President and Chief Executive Officer
31 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
25 Jan 2024 15:05:00 By Nasdaq GlobeNewswire
-
11 Jan 2024 15:30:00 By Nasdaq GlobeNewswire
-
08 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
27 Dec 2023 15:30:00 By Nasdaq GlobeNewswire
-
CVRx receives FDA approval for expanded labeling of Barostim
26 Dec 2023 07:05:00 By Nasdaq GlobeNewswire
-
CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference
15 Nov 2023 15:21:43 By Nasdaq GlobeNewswire
-
CMS Increases Outpatient Payment for Barostim Procedure
03 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
CVRx Reports Third Quarter 2023 Financial and Operating Results
26 Oct 2023 15:15:00 By Nasdaq GlobeNewswire
-
12 Oct 2023 15:30:00 By Nasdaq GlobeNewswire
-
CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference
27 Jul 2023 07:30:00 By Nasdaq GlobeNewswire
-
CVRx Reports Second Quarter 2023 Financial and Operating Results
25 Jul 2023 15:15:00 By Nasdaq GlobeNewswire
-
11 Jul 2023 15:30:00 By Nasdaq GlobeNewswire
-
CVRx Set to Join Russell 2000 & 3000 Indexes
22 Jun 2023 15:30:00 By Nasdaq GlobeNewswire
-
CVRx to Present at the William Blair 43rd Annual Growth Stock Conference
25 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
CVRx Reports First Quarter 2023 Financial and Operating Results
27 Apr 2023 15:15:00 By Nasdaq GlobeNewswire
-
20 Apr 2023 15:30:00 By Nasdaq GlobeNewswire
-
21 Mar 2023 10:02:23 By Nasdaq GlobeNewswire